Methotrexate Tablet
FDA Label NDC 50090-5457

49 label sections · Submitted to the FDA by A-s Medication Solutions · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Methotrexate (NDC 50090-5457). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: embryo-fetal toxicity, hypersensitivity reactions, severe adverse reactions, and risk of medication errors, 1.1 neoplastic diseases, 1.2 rheumatoid arthritis, 1.3 polyarticular juvenile idiopathic arthritis, 1.4 psoriasis, 2.1 important dosage and safety information, 2.2 recommended dosage for neoplastic diseases, 2.3 recommended dosage for rheumatoid arthritis, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.